01 6CATALYST PHARMS
01 110626088
02 110793893
03 111060128
04 111268128
05 111274331
06 111274332
01 6Blank
01 1Y
02 5Blank
01 42032-06-29
02 12034-05-26
03 12037-02-25
Patent Expiration Date : 2032-06-29
US Patent Number : 11274332
Drug Substance Claim :
Drug Product Claim :
Application Number : 208078
Patent Use Code : U-2956
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-06-29
Patent Expiration Date : 2032-06-29
US Patent Number : 11274331
Drug Substance Claim :
Drug Product Claim :
Application Number : 208078
Patent Use Code : U-2956
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-06-29
Patent Expiration Date : 2034-05-26
US Patent Number : 10793893
Drug Substance Claim :
Drug Product Claim :
Application Number : 208078
Patent Use Code : U-2956
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-05-26
Patent Expiration Date : 2032-06-29
US Patent Number : 11268128
Drug Substance Claim :
Drug Product Claim :
Application Number : 208078
Patent Use Code : U-2956
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-06-29
Patent Expiration Date : 2032-06-29
US Patent Number : 11060128
Drug Substance Claim :
Drug Product Claim :
Application Number : 208078
Patent Use Code : U-2956
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-06-29
Patent Expiration Date : 2037-02-25
US Patent Number : 10626088
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208078
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-25
